HomeCompareMKDVX vs JNJ

MKDVX vs JNJ: Dividend Comparison 2026

MKDVX yields 8.26% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MKDVX wins by $14.5K in total portfolio value
10 years
MKDVX
MKDVX
● Live price
8.26%
Share price
$20.56
Annual div
$1.70
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.6K
Annual income
$1,392.08
Full MKDVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MKDVX vs JNJ

📍 MKDVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMKDVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MKDVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MKDVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MKDVX
Annual income on $10K today (after 15% tax)
$701.97/yr
After 10yr DRIP, annual income (after tax)
$1,183.27/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MKDVX beats the other by $479.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MKDVX + JNJ for your $10,000?

MKDVX: 50%JNJ: 50%
100% JNJ50/50100% MKDVX
Portfolio after 10yr
$27.3K
Annual income
$1,109.93/yr
Blended yield
4.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MKDVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MKDVX buys
0
JNJ buys
0
No recent congressional trades found for MKDVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMKDVXJNJ
Forward yield8.26%3.36%
Annual dividend / share$1.70$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.6K$20.0K
Annual income after 10y$1,392.08$827.78
Total dividends collected$11.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MKDVX vs JNJ ($10,000, DRIP)

YearMKDVX PortfolioMKDVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,526$825.84$10,676$355.77+$850.00MKDVX
2$13,222$889.58$11,407$389.39+$1.8KMKDVX
3$15,102$953.75$12,198$426.53+$2.9KMKDVX
4$17,177$1,018.04$13,056$467.62+$4.1KMKDVX
5$19,461$1,082.18$13,987$513.12+$5.5KMKDVX
6$21,969$1,145.90$14,998$563.56+$7.0KMKDVX
7$24,716$1,208.96$16,098$619.52+$8.6KMKDVX
8$27,718$1,271.14$17,295$681.69+$10.4KMKDVX
9$30,990$1,332.24$18,599$750.82+$12.4KMKDVX
10$34,551$1,392.08$20,022$827.78+$14.5KMKDVX

MKDVX vs JNJ: Complete Analysis 2026

MKDVXStock

The fund seeks to achieve its objective by investing primarily in a diversified portfolio of equity securities. Under normal circumstances, it will invest at least 80% of its assets in equity securities and at least 80% of its assets in dividend paying securities. The fund may invest in securities of companies with any market capitalization, but will generally focus on large cap securities. It may also invest in convertible securities and non-convertible preferred stock. The fund may invest up to 25% of its total assets in securities of foreign issuers.

Full MKDVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MKDVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MKDVX vs SCHDMKDVX vs JEPIMKDVX vs OMKDVX vs KOMKDVX vs MAINMKDVX vs ABBVMKDVX vs MRKMKDVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.